Sagent Pharmaceuticals, Inc. 4
4 · Sagent Pharmaceuticals, Inc. · Filed Feb 23, 2016
Insider Transaction Report
Form 4
Drake Lorin
VP, Sales and Marketing
Transactions
- Award
Common Stock
2016-02-22+8,214→ 39,507 total - Tax Payment
Common Stock
2016-02-21$14.61/sh−449$6,560→ 31,628 total - Tax Payment
Common Stock
2016-02-22$13.00/sh−335$4,355→ 31,293 total - Award
Stock Option to Buy
2016-02-22+17,391→ 17,391 totalExercise: $14.61Exp: 2026-02-22→ Common Stock (17,391 underlying)
Footnotes (1)
- [F1]The option vests in four equal annual installments beginning on February 22, 2017.